US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Ongoing

Regular Strength Zantac 150 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Sanofi-Aventis U.S. LLC NDC 67751-151-01 D-0541-2020
Class II · Moderate risk Ongoing

Regular Strength Zantac 75 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Sanofi-Aventis U.S. LLC NDC 50269-222-25 D-0540-2020
Class II · Moderate risk Ongoing

Maximum Strength Zantac 150 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Sanofi-Aventis U.S. LLC D-0539-2020
Class II · Moderate risk Ongoing

Regular Strength Zantac 75 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Sanofi-Aventis U.S. LLC D-0535-2020
Class II · Moderate risk Terminated

Estradiol Vaginal Inserts USP

Reason Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.

Glenmark Pharmaceuticals Inc., USA NDC 68462-711-71 D-0156-2020
Class II · Moderate risk Terminated

Basic Reset CBD Reset 2400

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0194-2020
Class II · Moderate risk Terminated

Nuovi Firming Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0190-2020
Class II · Moderate risk Terminated

Basic Reset Nuovi Skin Toner

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0189-2020
Class II · Moderate risk Terminated

Miracle Facelift Masque

Reason Marketed without an Approved NDA/ANDA

Basic Reset Inc. D-0188-2020
Class II · Moderate risk Terminated

Prasugrel Tablets 5 mg

Reason Failed Dissolution Specification: Low out of specification dissolution results.

Mylan Pharmaceuticals Inc. NDC 0378-5185-93 D-0155-2020
Class II · Moderate risk Terminated

Viatrexx-ANS/CNS

Reason Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

8046255 Canada Inc. DBA Viatrexx NDC 73069-039-41 D-0348-2020
Class II · Moderate risk Terminated

Viatrexx-Male+

Reason Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.

8046255 Canada Inc. DBA Viatrexx NDC 73069-320-41 D-0347-2020